Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Publication of PA8841501A1publicationCriticalpatent/PA8841501A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A UNA COMPOSICIÓN FARMACÉUTICA ORAL SÓLIDA QUE COMPRENDE FLUCONAZOL,TINIDAZOL Y CLINDAMICINA O UNA SAL FARMACÉUTICAMENTE ACEPTABLE DE LOS MISMOS,DONDE EL CONTENIDO DE EXCIPIENTES FARMACÉUTICAMENTE ACEPTABLES ES SIGNIFICATIVAMENTE MENOR QUE EL CONTENIDO QUE LOS PRINCIPIOS ACTIVOS,EL USO DE DICHA COMPOSICIÓN PARA LA ADMINISTRACIÓN ORAL CON ACTIVIDAD TERAPÉUTICA PARA EL TRATAMIENTO DE INFECCIONES DE TRAMISIÓN SEXUAL.THE PRESENT INVENTION REFERS TO A SOLID ORAL PHARMACEUTICAL COMPOSITION THAT INCLUDES FLUCONAZOL, TINIDAZOL AND CLINDAMYCIN OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, WHERE THE CONTENT OF PHARMACEUTICALLY EXCIPIENTS THAT ACCEPTS THE PRINCIPLE USE OF THE COMPACT FOR ORAL ADMINISTRATION WITH THERAPEUTIC ACTIVITY FOR THE TREATMENT OF SEXUAL PROCESSING INFECTIONS.
PA8841501A2008-09-042009-09-04
PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF SEXUAL TRANSMISSION INFECTIONS
PA8841501A1
(en)
Use of an oral transmucosal pharmaceutical composition comprising dexmedetomidine and a pharmaceutically acceptable salt and a pharmaceutically acceptable excipient to prepare a medicament useful for treating or preventing pain.
A method for treating an infection in a subject comprising the administration of 9 - [(2,2-dimethyl-propylamino) -methyl] -minocycline or a salt thereof; pharmaceutical composition comprising said compound; and its use.
PHARMACEUTICAL COMPOSITION OF SOLID DOSAGE INCLUDING VALSARTAN, AMLODIPINA, HYDROCHLOROTIAZIDA AND PHARMACEUTICALLY ACCEPTABLE ADDITIVES; PREPARATION PROCEDURE; AND USE FOR THE TREATMENT OF HYPERTENSION, CARDIAC INSUFFICIENCY, INFARTO D
2-aminopyrimidine derived compounds, h4 receptor antagonists; preparation procedure; pharmaceutical composition comprising said compound; and use of the compound in the treatment of an allergic, immunological or inflammatory disease or pain.
METHOD FOR TREATMENT OF ATTRACTIONS OR COMPULSIVE FOOD INGESTION; USE OF BUPROPRION AND NALTREXONE TO PREPARE A MEDICINAL PRODUCT FOR SUCH METHODS, AND PHARMACEUTICAL COMPOSITION
Use of a topical composition comprising 3.75% imiquimod and a pharmaceutically acceptable carrier to prepare a medicament useful for treating genital or perianal warts.
USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THIS, FOR THE PREPARATION OF A MEDICINAL PRODUCT TO REGULATE THE LEVEL OF POTASSIUM IN THE BLOOD
Pharmaceutical composition for injection that compensates for an aqueous solution of ibuprofen and trometamol, in which the concentration of ibuprofen is between 2 and 6 mg / ml, the concentration of trometamol is between 1.8 and 5.8 mg / ml, and the pH is between 7.0 and 9.5; and its use for the treatment of pain, inflammation or fever.